NST — Nestmedic SA Income Statement
0.000.00%
Last trade - 00:00
- PLN28.33m
- PLN29.14m
- PLN1.71m
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | PAS | PAS | PAS | PAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.408 | 0.371 | 0.655 | 1.87 | 1.71 |
Cost of Revenue | |||||
Gross Profit | -1.66 | -1.27 | -2.32 | -3.32 | -3.45 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.48 | 4.24 | 4.2 | 6.52 | 7.78 |
Operating Profit | -5.08 | -3.87 | -3.55 | -4.65 | -6.08 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.32 | -4.24 | -3.91 | -4.95 | -6.48 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.32 | -4.24 | -3.91 | -4.95 | -6.48 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.32 | -4.24 | -3.91 | -4.95 | -6.48 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.32 | -4.24 | -3.91 | -4.95 | -6.48 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.789 | -0.588 | -0.419 | -0.263 | -0.28 |
Dividends per Share |